We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Fatigue and Cancer Treatment(FACT)- an Exercise Intervention

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00181129
Recruitment Status : Completed
First Posted : September 16, 2005
Last Update Posted : September 30, 2008
Information provided by:
Johns Hopkins University

Brief Summary:
The purpose of this randomized controlled trial is to determine the effects of a nurse-directed, home-based walking exercise program to mitigate fatigue and maintain physical functioning during adjuvant therapy for cancer. The sample will be randomized into exercise (EX) or usual care (UC) groups. The independent study variable is participation in a walking exercise program. Outcomes include: fatigue, sleep disturbance, emotional distress, physical functioning and quality of life. The effects of the walking exercise program will be evaluated using self-report questionnaires administered pre- and post-treatment, patient diaries, and symptoms assessments at defined intervals during adjuvant therapy

Condition or disease Intervention/treatment
Cancer, Fatigue Behavioral: home based self paced walking program

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 140 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Official Title: Mitigating Cancer Treatment-Related Fatigue by Exercise
Study Start Date : September 2002

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   21 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

Confirmed diagnosis of cancer (Stage 1,2,or 3),

21 years of age or older,

Free of cognitive or physical deficits that would preclude entry into study,

not currently exercising 120 min/wk or more

Exclusion Criteria:

Concurrent major health problems or disabilities that would limit participation in an exercise program.

Stage 4 cancer (metastisis)

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00181129

United States, Maryland
Johns Hopkins University School of Nursing
Baltimore, Maryland, United States, 21205
Sponsors and Collaborators
Johns Hopkins University
Principal Investigator: Victoria L Mock, DNSc Johns Hopkins University School of Nursing

ClinicalTrials.gov Identifier: NCT00181129     History of Changes
Other Study ID Numbers: NINR:RO1NRO4991
First Posted: September 16, 2005    Key Record Dates
Last Update Posted: September 30, 2008
Last Verified: September 2008

Keywords provided by Johns Hopkins University:
Cancer treatment

Additional relevant MeSH terms:
Signs and Symptoms